The overarching goal of the Meharry RCTR (MeTRC) is to expand and strengthen the overall research infrastructure at Meharry Medical College (MMC) for conducting and promoting clinical and translational research (CTR) in health disparities, with a major emphasis to reduce or eliminate disease burden in minorities regarding inflammatory diseases, HIV/AIDS, diabetes/obesity, cancer and neurological diseases. We will achieve this by (1) providing effective and highly dynamic leadership to expand and promote the infrastructure to support innovative CTR discoveries which address the science of health disparities; (2) foster sustained, productive intra- and inter-institutional collaborations that san the translational research spectrum and will include basic, social and behavioral scientists, clinical researchers and community-based researchers; (3) expand and strengthen professional development to foster mentorship and promotion of investigators towards successful establishment of competitive and externally funded CTR projects; (4) develop and implement a plan for self-evaluation of short- and long-term RCTR goals including implementation and tracking of program activities; (5) expand CTR capacity by recruiting additional clinician-scientists and community-based-participatory research (CBPR) investigators; (6) enhance CTR enterprise by further developing our research infrastructure, including developing data warehouses, management and integration of hardware and software systems; (7) enhance research design, biostatistical analysis and clinical research ethics and related research training opportunities; (8) enhance the infrastructure to improve minority participation in CTR by providing an environment that fosters patient interactions involving intra- and inter-institutional collaborations; (9) expand and promote the community engagement in innovative CTR that increases the capacity of investigators to efficiently conduct qualitative CBPR, as well as expand the use of communication strategies that are sensitive to literacy, cultural differences and psychosocial factors; (10) enhance research support services to assist investigators in navigating the complex regulatory environment surrounding the conduct of CTR, while fostering and maintaining a culture of compliance; (11) enhance technical and support infrastructure to accelerate research discovery in clinical and translational sciences such as proteomics, genomics, cell and tissue imaging, advanced data analysis and other data intensive research areas; (12) build upon our previous T1 research success support of highly competitive interdisciplinary collaborative pilot project research clusters/program that promote health disparity research along the T2-T4 translational research trajectory.

Public Health Relevance

The Meharry Clinical Translational Research Center (MeTRC) will provide an environment for conducting and promoting clinical and translational research in health disparities that seek to reduce or eliminate disease burden in minorities. Research will focus primarily on inflammatory/infectious diseases, diabetes, cardiovascular diseases, cancer and neurological disorders that affect the populations we serve.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54MD007593-10
Application #
9471246
Study Section
Special Emphasis Panel (ZMD1)
Program Officer
Das, Rina
Project Start
2009-09-30
Project End
2019-04-30
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
10
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Meharry Medical College
Department
Biochemistry
Type
Schools of Medicine
DUNS #
041438185
City
Nashville
State
TN
Country
United States
Zip Code
37208
Luo, Wentian; Olaru, Florina; Miner, Jeffrey H et al. (2018) Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy. Front Immunol 9:1433
Walker, Miriam Y; Pratap, Siddharth; Southerland, Janet H et al. (2018) Role of oral and gut microbiome in nitric oxide-mediated colon motility. Nitric Oxide 73:81-88
Archibong, Anthony E; Rideout, Meredith L; Harris, Kenneth J et al. (2018) OXIDATIVE STRESS IN REPRODUCTIVE TOXICOLOGY. Curr Opin Toxicol 7:95-101
Smith Jr, Joseph T; Singha, Ujjal K; Misra, Smita et al. (2018) Divergent Small Tim Homologues Are Associated with TbTim17 and Critical for the Biogenesis of TbTim17 Protein Complexes in Trypanosoma brucei. mSphere 3:
Smith, Keisha; Nayyar, Sanket; Rana, Tanu et al. (2018) Do Progestin-Only Contraceptives Contribute to the Risk of Developing Depression as Implied by Beta-Arrestin 1 Levels in Leukocytes? A Pilot Study. Int J Environ Res Public Health 15:
Ochieng, Josiah; Nangami, Gladys; Sakwe, Amos et al. (2018) Extracellular histones are the ligands for the uptake of exosomes and hydroxyapatite-nanoparticles by tumor cells via syndecan-4. FEBS Lett 592:3274-3285
Abney, Kristopher K; Ramos-Hunter, Susan J; Romaine, Ian M et al. (2018) Selective Activation of N,N'-Diacyl Rhodamine Pro-fluorophores Paired with Releasing Enzyme, Porcine Liver Esterase (PLE). Chemistry 24:8985-8988
Balasubramaniam, Muthukumar; Pandhare, Jui; Dash, Chandravanu (2018) Are microRNAs Important Players in HIV-1 Infection? An Update. Viruses 10:
Sanjay, Sharma T; Zhou, Wan; Dou, Maowei et al. (2018) Recent advances of controlled drug delivery using microfluidic platforms. Adv Drug Deliv Rev 128:3-28
Ho, Meng-Hsuan; Lamont, Richard J; Chazin, Walter J et al. (2018) Characterization and development of SAPP as a specific peptidic inhibitor that targets Porphyromonas gingivalis. Mol Oral Microbiol 33:430-439

Showing the most recent 10 out of 164 publications